Screener
Silicon Laboratories SLAB Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Silicon Laboratories in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Silicon Laboratories’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001038074-26-000020
| Line item | Three Months Ended / April 4,2026 | Three Months Ended / April 5,2025 |
|---|---|---|
| Proceeds from capital-related government incentives | 1,265 | — |
| Net cash provided by (used in) investing activities | 14,889 | (3,900) |
| Financing Activities | ||
| Payment of taxes withheld for vested stock awards | (956) | (958) |
| Net cash used in financing activities | (956) | (958) |
| Increase in cash and cash equivalents | 18,867 | 43,270 |
| Cash and cash equivalents at beginning of period | 364,222 | 281,607 |
| Cash and cash equivalents at end of period | $383,089 | $324,877 |
Item 1. Financial Statements (Unaudited):
FAQ
- What is Silicon Laboratories's cash & equivalents?
- Silicon Laboratories (SLAB) reported cash & equivalents of $383.09M in Q1 2026.
- How has Silicon Laboratories's cash & equivalents changed year-over-year?
- Silicon Laboratories's cash & equivalents increased by 17.9% year-over-year, from $324.88M to $383.09M.
- What is the long-term trend for Silicon Laboratories's cash & equivalents?
- Over 5 years (2020 to 2025), Silicon Laboratories's cash & equivalents has grown at a 12.4% compound annual growth rate (CAGR), from $202.72M to $364.22M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Silicon Laboratories's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude